These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24374203)

  • 21. Mesenchymal stem cell therapy ameliorates diabetic hepatocyte damage in mice by inhibiting infiltration of bone marrow-derived cells.
    Nagaishi K; Ataka K; Echizen E; Arimura Y; Fujimiya M
    Hepatology; 2014 May; 59(5):1816-29. PubMed ID: 24375439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of telmisartan on the expression of cardiac adiponectin and its receptor 1 in type 2 diabetic rats.
    Guo Z; Zheng C; Qin Z; Wei P
    J Pharm Pharmacol; 2011 Jan; 63(1):87-94. PubMed ID: 21155820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of mesenchymal stem cells transplantation on glycaemic profile & their localization in streptozotocin induced diabetic Wistar rats.
    Bhansali S; Kumar V; Saikia UN; Medhi B; Jha V; Bhansali A; Dutta P
    Indian J Med Res; 2015 Jul; 142(1):63-71. PubMed ID: 26261168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The reverse remodeling effect of mesenchymal stem cells is independent from the site of epimyocardial cell transplantation.
    Arsalan M; Dhein S; Aupperle H; Rastan AJ; Barten MJ; Walther T; Mohr FW; Garbade J
    Innovations (Phila); 2013; 8(6):433-9. PubMed ID: 24225815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved anti-apoptotic and anti-remodeling potency of bone marrow mesenchymal stem cells by anoxic pre-conditioning in diabetic cardiomyopathy.
    Li JH; Zhang N; Wang JA
    J Endocrinol Invest; 2008 Feb; 31(2):103-10. PubMed ID: 18362500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cardiac neural stem cell phenotype is compromised in streptozotocin-induced diabetic cardiomyopathy.
    El-Helou V; Proulx C; Béguin P; Assimakopoulos J; Gosselin H; Clement R; Villeneuve L; Huot-Marchand JE; Deblois D; Lajoie C; Calderone A
    J Cell Physiol; 2009 Aug; 220(2):440-9. PubMed ID: 19388005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow-derived mesenchymal stem cells improve islet graft function in diabetic rats.
    Figliuzzi M; Cornolti R; Perico N; Rota C; Morigi M; Remuzzi G; Remuzzi A; Benigni A
    Transplant Proc; 2009 Jun; 41(5):1797-800. PubMed ID: 19545731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transplantation of mesenchymal stem cells recruits trophic macrophages to induce pancreatic beta cell regeneration in diabetic mice.
    Cao X; Han ZB; Zhao H; Liu Q
    Int J Biochem Cell Biol; 2014 Aug; 53():372-9. PubMed ID: 24915493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stem cells: a future experimental exploration for recession of diabetic nephropathy.
    Hamza AH; Al-Bishri WM; Damiati LA; Ahmed HH
    Ren Fail; 2017 Nov; 39(1):67-76. PubMed ID: 27774826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Betacellulin overexpression in mesenchymal stem cells induces insulin secretion in vitro and ameliorates streptozotocin-induced hyperglycemia in rats.
    Paz AH; Salton GD; Ayala-Lugo A; Gomes C; Terraciano P; Scalco R; Laurino CC; Passos EP; Schneider MR; Meurer L; Cirne-Lima E
    Stem Cells Dev; 2011 Feb; 20(2):223-32. PubMed ID: 20836700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of angiotensin-converting enzyme 2 improves cardiac electrical changes in ventricular repolarization in streptozotocin-induced hyperglycaemic rats.
    Coutinho DC; Monnerat-Cahli G; Ferreira AJ; Medei E
    Europace; 2014 Nov; 16(11):1689-96. PubMed ID: 24741027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes.
    Urbán VS; Kiss J; Kovács J; Gócza E; Vas V; Monostori E; Uher F
    Stem Cells; 2008 Jan; 26(1):244-53. PubMed ID: 17932424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin treatment of diabetic rats reduces cardiac function in a lipopolysaccharide-induced systemic inflammation model.
    Hagiwara S; Iwasaka H; Kudo K; Hasegawa A; Kusaka J; Uchida T; Noguchi T
    J Surg Res; 2011 Nov; 171(1):251-8. PubMed ID: 20638685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preservation of ventricular performance at early stages of diabetic cardiomyopathy involves changes in myocyte size, number and intercellular coupling.
    Stilli D; Lagrasta C; Berni R; Bocchi L; Savi M; Delucchi F; Graiani G; Monica M; Maestri R; Baruffi S; Rossi S; Macchi E; Musso E; Quaini F
    Basic Res Cardiol; 2007 Nov; 102(6):488-99. PubMed ID: 17585379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction.
    Dong F; Harvey J; Finan A; Weber K; Agarwal U; Penn MS
    Circulation; 2012 Jul; 126(3):314-24. PubMed ID: 22685115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid hormone improves the mechanical performance of the post-infarcted diabetic myocardium: a response associated with up-regulation of Akt/mTOR and AMPK activation.
    Mourouzis I; Giagourta I; Galanopoulos G; Mantzouratou P; Kostakou E; Kokkinos AD; Tentolouris N; Pantos C
    Metabolism; 2013 Oct; 62(10):1387-93. PubMed ID: 23773982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic transplantation of fetal membrane-derived mesenchymal stem cell sheets increases neovascularization and improves cardiac function after myocardial infarction in rats.
    Ishikane S; Hosoda H; Yamahara K; Akitake Y; Kyoungsook J; Mishima K; Iwasaki K; Fujiwara M; Miyazato M; Kangawa K; Ikeda T
    Transplantation; 2013 Oct; 96(8):697-706. PubMed ID: 23912174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bone marrow mesenchymal stem cell therapy on diabetic nephropathy in rats].
    Zhou H; Gao Y; Tian HM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 40(6):1024-8. PubMed ID: 20067112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous administration of bone marrow mesenchymal stromal cells is safe for the lung in a chronic myocardial infarction model.
    Wang W; Jiang Q; Zhang H; Jin P; Yuan X; Wei Y; Hu S
    Regen Med; 2011 Mar; 6(2):179-90. PubMed ID: 21391852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrapancreatic injection of human bone marrow-derived mesenchymal stem/stromal cells alleviates hyperglycemia and modulates the macrophage state in streptozotocin-induced type 1 diabetic mice.
    Murai N; Ohtaki H; Watanabe J; Xu Z; Sasaki S; Yagura K; Shioda S; Nagasaka S; Honda K; Izumizaki M
    PLoS One; 2017; 12(10):e0186637. PubMed ID: 29073149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.